Needle-Free Vaccine Candidate R&D and Early-Phase Clinical Trials

This subcontract focuses on the research, design, and early-phase clinical testing of needle-free vaccine candidates to support prime contractors on NIH/NIAID infectious disease projects. The scope of work includes executing early-phase clinical trials, generating essential proof-of-concept data, and implementing non-animal testing methodologies. To successfully perform these tasks, the contractor must utilize high-containment BSL laboratory facilities, clinical trial management systems, and adhere to strict biosafety and biosecurity standards. Managed under the Department of Health and Human Services for the National Institutes of Health NIAID, the project requires the delivery of comprehensive clinical trial reports and a viable vaccine candidate. Interested parties should note the response deadline of December 8, 2026. The work is categorized under NAICS code 541380, emphasizing the specialized technical and scientific nature of the required research and development services.